ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Besides, abnormal DNA damage repairs result in chromosomal changes due to cellular ABL kinase inhibited by TKIs.[13] Additionally, as the case described here, the type of TKI drugs or therapeutic change is probably related to the occurrence of AML rising from CML with Ph chromosome negative.